PORTRAZZA 16 MG
NECITUMUMAB : 16 MG · DIN 02462478 · ELI LILLY CANADA INC
Health Canada status: CANCELLED PRE MARKET
What is PORTRAZZA?
PORTRAZZA 16 MG contains NECITUMUMAB : 16 MG. It is listed in the Health Canada Drug Product Database under DIN 02462478, held by ELI LILLY CANADA INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled pre market, status dated 22-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02462478 |
|---|---|
| Brand name | PORTRAZZA |
| Generic / active ingredient | NECITUMUMAB : 16 MG |
| Manufacturer | ELI LILLY CANADA INC |
| Strength | 16 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Schedule D |
| ATC code | L01FE03 NECITUMUMAB |
| AHFS class | 72:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 22-Jul-2021 |
| Original market date | 2021-06-09 00:00:00 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.